TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, was linked to Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments found effects on amyloid and tau, but the human findings are observational and do not establish that ImP causes Alzheimer’s or that lowering it prevents disease.
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, may be connected to Alzheimer’s-related brain changes: in mice it increased abnormal amyloid and tau accumulation, while higher blood levels in nearly 1,200 people were associated with disease-related markers and faster cognitive decline. The study, published in Nature Communications, identifies a possible research target, but does not show that ImP causes Alzheimer’s in people or that reducing it would prevent the disease.
The team, led by researchers at the University of Wisconsin–Madison, examined ImP, which certain intestinal bacteria produce while using histidine, an amino acid found in many foods. The molecule can enter the bloodstream and reach other parts of the body. Earlier research had linked ImP with type 2 diabetes and coronary artery disease; the new work examined whether it might also be relevant to dementia.
In mouse experiments, ImP reaching the brain was associated with increased accumulation of abnormal beta-amyloid and tau proteins, both associated with Alzheimer’s disease. The researchers also analyzed blood samples from almost 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies through the Wisconsin Alzheimer’s Disease Research Center. Higher ImP concentrations were associated with biological markers of abnormal proteins and impaired neuron function.
Participants had completed cognitive tests over time, allowing researchers to compare blood ImP levels with changes in thinking and memory. People with the highest levels showed faster cognitive decline, the study authors reported. The team also identified a genetic variation associated with higher circulating ImP; about 43% of participants carried it. The researchers suspect the variation may affect how efficiently the kidneys clear ImP, but that explanation remains a hypothesis.
A Possible Target Beyond Diet
The findings point to a potential connection between the gut microbiome and brain health through a specific molecule, rather than treating gut bacteria as a single, undifferentiated factor. If further research confirms that ImP contributes to disease processes, it could give scientists a target for therapies intended to lower the molecule or limit its effects.
The study does not establish that changing ImP levels would change a person’s risk or the course of dementia. The authors also caution that avoiding histidine is not a straightforward strategy: it is an essential amino acid present in many foods, particularly protein-rich foods. The research therefore supports investigation of targeted approaches, not a specific dietary prescription or a current prevention method.
Products Worth Considering
Dyson V8 Cyclone Cordless Vacuum
Ring Outdoor Cam 4K Plus Battery Security Camera, 3-Pack, White
Philips Hue Large Smart Light Tube, Black – White and Color Ambiance LED Color-Changing Light – 1 Pack
As an affiliate, we earn on qualifying purchases.
From Gut Microbes to Brain
The Wisconsin research team has studied possible links between intestinal microbes and Alzheimer’s for years. Nearly a decade before this report, work led by professors Barbara Bendlin and Federico Rey found differences in gut microbial communities between people with Alzheimer’s and healthy individuals. The researchers have since been investigating how such differences might relate to changes in the brain.
ImP production varies among people. Bacteria capable of producing it appear to be present in many people, though the researchers say they are not abundant in most. Rey has emphasized that a microbe does not need to be plentiful to affect its host. The new study builds on that line of research by examining a candidate bacterial product, its presence in blood, and its possible relationship to brain and cognitive outcomes. Scientists from UCLA and the University of Gothenburg also contributed.
“Generally improving your diet would probably help. But it’s not as easy as saying, ‘Stop eating eggs’ or ‘Don’t eat so much red meat.’ Because you need histidine, and it’s all over the place.”
— Barbara Bendlin, University of Wisconsin–Madison professor of medicine
Cause, Risk and Treatment Still Unproven
The human results show associations, not proof that ImP causes Alzheimer’s or accelerates decline. Other factors could contribute to both elevated ImP and cognitive changes. The mouse findings offer evidence of effects in that model, but they do not establish that the same process occurs in people or that changing ImP would alter clinical outcomes.
The proposed kidney-clearance explanation for the genetic variation has not been confirmed in the supplied report. It is also unclear whether the association applies broadly beyond the study participants, how ImP levels change over time, and what level—if any—would be a meaningful treatment target. No ImP-lowering drug or prevention benefit was reported.
Testing ImP-Lowering Strategies
The next step is further research to test whether ImP directly contributes to disease-related changes in people and to clarify how the genetic variation affects blood levels. Researchers would also need to establish whether an intervention can safely reduce ImP and whether that reduction changes Alzheimer’s-related markers or cognitive outcomes.
Bendlin and colleagues have raised the possibility of developing an inhibitor that lowers ImP, comparing the idea to medicines that reduce cholesterol. That remains a proposed research direction, not a treatment currently shown to prevent Alzheimer’s. Until studies test such an approach, the report does not support avoiding particular foods or making medical decisions based on ImP levels.
Key Questions
What is imidazole propionate?
Imidazole propionate (ImP) is a molecule produced by some gut bacteria as they use histidine, an amino acid. It can enter the bloodstream.
Does the study prove ImP causes Alzheimer’s disease?
No. The human findings show an association between higher blood ImP, Alzheimer’s-related markers and faster cognitive decline. They do not establish cause and effect.
Did researchers find a treatment that lowers Alzheimer’s risk?
No treatment was tested or reported as effective. The authors suggested that an ImP-lowering inhibitor could be a future research target.
Should people avoid histidine-rich foods?
The study does not recommend avoiding them. Histidine is essential and occurs in many foods; the researchers said dietary reduction would not be a simple approach.
Source: rss
